Welcome to our dedicated page for NICE Ltd. SEC filings (Ticker: NCSYF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
NICE Ltd. filings document the company's foreign-private-issuer reporting through Form 6-K submissions. The records include furnished press releases and exhibits on GAAP financial statements, cloud revenue, AI annual recurring revenue, share repurchases, and financial outlook, with selected financial statements incorporated by reference into Form S-8 registration statements for equity compensation plans.
The filings also record product and customer announcements for NiCE CXone, NiCE Cognigy, and NICE Actimize, including contact-center-as-a-service, AI agents, interaction analytics, fraud detection, financial-crime risk management, and KYC solutions. Governance disclosures cover special general meeting notices, record dates, proxy and electronic voting mechanics, and instructions for American Depositary Share holders.
NICE Ltd. Chief Executive Officer Russell Scott Edward reported his initial ownership in the company. He directly holds 65,989 Ordinary Shares and has Performance Share Units linked to 27,500 underlying Ordinary Shares.
Footnotes add that his equity awards include 33,000 restricted stock units and 16,500 performance stock units, each representing a contingent right to receive one Ordinary Share, vesting under their award terms. Certain performance share units are eligible to vest over a three-year period ending January 1, 2028 based on specified stock price performance thresholds.
NICE Ltd. director Ben-Shaoul Rimon filed an initial Form 3 reporting his equity holdings in the company. He directly owns 995 Ordinary Shares and a series of employee stock options over additional Ordinary Shares with varying exercise prices and expiration dates.
These options include grants exercisable for 3,980 shares at an exercise price of 151.6300 per share expiring on April 30, 2026, and others such as 2,785 shares at 224.1800 per share expiring on September 10, 2026. Footnotes state that some options are fully vested and currently exercisable, while others vest in installments through September 30, 2026.
NICE Ltd. director Leo Apotheker filed an initial ownership report showing multiple stock option grants over Ordinary Shares. The options cover various underlying share amounts with exercise prices such as 224.1800 and 144.9030 and expiration dates from 2026 through 2031, with some already fully vested and others vesting through September 30, 2026.
NICE Ltd. director Joseph Lamar Cowan filed an initial Form 3 detailing his equity stake in the company. He reports direct ownership of 4,769 Ordinary Shares, which includes 746 restricted stock units that vest under the terms of their awards, each representing one Ordinary Share.
Cowan also reports indirect ownership of 11,183 Ordinary Shares held by a corporation, and several option grants over Ordinary Shares. These stock options carry exercise prices ranging from $144.9030 to $232.2005 per share and expire between April 2026 and September 2031, with some fully vested and others scheduled to vest in installments during 2026.
NICE Ltd. director David Kostman filed an initial Form 3 reporting his beneficial ownership. He directly holds 19,146 Ordinary Shares, which include 1,744 RSUs and 7,635 ADRs, each ADR representing one Ordinary Share. He also reports multiple option awards over Ordinary Shares, such as options exercisable for 14,920 shares at an exercise price of $151.63 expiring on April 30, 2026 and options for 10,423 shares at $224.18 expiring on September 10, 2026, along with additional grants extending through 2031. The filing records current holdings and does not show new purchases or sales.
NICE Ltd. filed an initial Form 3 for director Dan Michael Falk, detailing his existing stock option holdings in the company’s ordinary shares. The filing lists multiple option awards with different exercise prices and expiration dates ranging from 2026 through 2031.
Some options, including grants covering ordinary shares at exercise prices such as 224.1800 and 144.9030, are fully vested and currently exercisable. One grant is already exercisable for 746 ordinary shares and is scheduled to vest in three substantially equal installments on March 30, 2026, June 30, 2026, and September 30, 2026. Another option grant will fully vest on September 30, 2026. The form records holdings only and does not report new purchases or sales.
NICE Ltd. director Caroline J. Tsay filed an initial ownership report showing equity awards rather than new share purchases or sales. She holds options linked to 2,987 Ordinary Shares at an exercise price of $144.9030 per share, expiring on September 30, 2031. These options are already vested for 746 Ordinary Shares and will vest for the remaining shares in three substantially equal installments on March 30, 2026, June 30, 2026, and September 30, 2026. She also holds 746 Restricted Share Units, each representing a contingent right to receive one Ordinary Share, which will vest under the terms of the applicable awards.
NICE Ltd. Chief Financial Officer Mary Beth Gaspich filed an initial ownership report showing her equity stake in the company. She directly holds 62,121 Ordinary Shares, which include 32,615 restricted stock units (RSUs) and 15,910 performance stock units (PSUs), each convertible into one Ordinary Share as they vest under their award terms. She also holds Performance Share Units representing a contingent right to receive 5,000 Ordinary Shares, eligible to vest over a three-year performance period ending February 18, 2029. These units may be earned between 0%-200% of target levels based on the company’s stock price performance against specified thresholds.
NICE Ltd. executive Levy Meir Alon, VP, General Counsel & Corporate Secretary, reports holding stock options tied to 1,800 Ordinary Shares. These options carry an exercise price of 0.3108 and expire on November 11, 2031.
According to the vesting schedule, the option will vest in substantially equal installments on September 1, 2026, September 1, 2027, September 1, 2028 and September 1, 2029. This Form 3 serves as an initial statement of this derivative holding.
NICE Ltd. furnished a Form 6-K highlighting two AI-focused milestones. First, its NiCE Cognigy platform was recognized as the only vendor to receive the Customers’ Choice distinction in the 2025 Gartner Peer Insights Voice of the Customer for Enterprise Conversational AI Platforms, based on verified user reviews and a 4.8/5 rating from 138 ratings as of January 14, 2026.
Second, NICE released The Agentic AI CX Frontline report, which shares live enterprise benchmarks for AI-first customer experience, including 3x faster deployments, containment rates exceeding 80%, double-digit reductions in cost per contact, and customer satisfaction gains of up to 20% for large organizations using Agentic AI at scale.